Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
This study pioneered an in vivo self-assembly strategy to develop a PKM2 allosteric converter, dually suppressing the Warburg effect and chemoresistance in renal cell carcinoma (RCC) through an enzyme-responsive self-assembly and sustained activation mechanism
: Beauty & Personal Care
Composition & Format Active ingredients: BPC-157 peptide 5 mg + TB-500 peptide 5 mg (10 mg total per vial) Purity: high-purity peptide material (99%) Format: white lyophilized powder in sealed glass vials Standard strength per vial: 10 mg (5 mg + 5 mg) Standard kit configuration: 10 vials/kit Key Features for Wholesale Buyers China-based factory supply focused on healing & recovery peptide blends Balanced 5 mg + 5 mg ratio commonly used in soft-tissue and recovery-oriented study designs Lyophilized powder format for flexible storage, reconstitution and protocol planning Suitable for labs evaluating BPC-157 and TB-500 together instead of managing two separate SKUs OEM & private-label options available for qualified wholesale and distribution partners Packaging & Ordering Standard packaging: 10 mg/vial (5 mg + 5 mg), 10 vials/kit in protective trays and outer cartons Typical MOQ is 1 kit for evaluation
Glucose starvation activates AMPK, which promotes phosphorylation of BECN1 at the S90 and S93 sites, leading to increased binding of BEC7A11 to SLC7A11 and decreased SLC7A11 binding
US$ 23.33
US$ 20.21
US$ 23.86
US$ 27.81
US$ 24.29
US$ 21.04
US$ 27.24
